These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 14871154)

  • 1. Pharmacokinetics of Ibuprofen in children with cystic fibrosis.
    Han EE; Beringer PM; Louie SG; Gill MA; Shapiro BJ
    Clin Pharmacokinet; 2004; 43(3):145-56. PubMed ID: 14871154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of population pharmacokinetic models and optimal sampling times for ibuprofen tablet and suspension formulations in children with cystic fibrosis.
    Beringer P; Aminimanizani A; Synold T; Scott C
    Ther Drug Monit; 2002 Apr; 24(2):315-21. PubMed ID: 11897978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ibuprofen in patients with cystic fibrosis.
    Murry DJ; Oermann CM; Ou CN; Rognerud C; Seilheimer DK; Sockrider MM
    Pharmacotherapy; 1999 Mar; 19(3):340-5. PubMed ID: 10221372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of high dose ibuprofen in cystic fibrosis.
    Arranz I; Martín-Suárez A; Lanao JM; Mora F; Vázquez C; Escribano A; Juste M; Mercader J; Ripoll E
    Arch Dis Child; 2003 Dec; 88(12):1128-30. PubMed ID: 14670788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of ibuprofen enantiomers in children with cystic fibrosis.
    Dong JQ; Ni L; Scott CS; Retsch-Bogart GZ; Smith PC
    J Clin Pharmacol; 2000 Aug; 40(8):861-8. PubMed ID: 10934670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of High-Dose Ibuprofen Use, Lung Function Decline, and Long-Term Survival in Children with Cystic Fibrosis.
    Konstan MW; VanDevanter DR; Sawicki GS; Pasta DJ; Foreman AJ; Neiman EA; Morgan WJ
    Ann Am Thorac Soc; 2018 Apr; 15(4):485-493. PubMed ID: 29313709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ibuprofen in children with cystic fibrosis: pharmacokinetics and adverse effects.
    Konstan MW; Hoppel CL; Chai BL; Davis PB
    J Pediatr; 1991 Jun; 118(6):956-64. PubMed ID: 2040934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of high-dose ibuprofen in a pediatric cystic fibrosis center.
    Fennell PB; Quante J; Wilson K; Boyle M; Strunk R; Ferkol T
    J Cyst Fibros; 2007 Apr; 6(2):153-8. PubMed ID: 16844429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose ibuprofen in cystic fibrosis: Canadian safety and effectiveness trial.
    Lands LC; Milner R; Cantin AM; Manson D; Corey M
    J Pediatr; 2007 Sep; 151(3):249-54. PubMed ID: 17719932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ibuprofen therapy in cystic fibrosis.
    Lands LC
    Pediatr Pulmonol; 2000 Mar; 29(3):244-5. PubMed ID: 10686050
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of ibuprofen on neutrophil migration in vivo in cystic fibrosis and healthy subjects.
    Konstan MW; Krenicky JE; Finney MR; Kirchner HL; Hilliard KA; Hilliard JB; Davis PB; Hoppel CL
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1086-91. PubMed ID: 12807998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vitro model for assessing drug transport in cystic fibrosis treatment: Characterisation of the CuFi-1 cell line.
    Sheikh Z; Bradbury P; Pozzoli M; Young PM; Ong HX; Traini D
    Eur J Pharm Biopharm; 2020 Nov; 156():121-130. PubMed ID: 32916267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose ibuprofen therapy associated with esophageal ulceration after pneumonectomy in a patient with cystic fibrosis: a case report.
    Mackey JE; Anbar RD
    BMC Pediatr; 2004 Sep; 4():19. PubMed ID: 15363106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ibuprofen therapy and nasal polyposis in cystic fibrosis patients.
    Lindstrom DR; Conley SF; Splaingard ML; Gershan WM
    J Otolaryngol; 2007 Oct; 36(5):309-14. PubMed ID: 17963671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory and pharmacokinetics evaluation of PEGylated ibuprofen tablet formulation.
    Mumuni M; Kenechukwu FC; Chime SA; Ogbonna JD; Mora AT
    Drug Deliv; 2014 Jun; 21(4):315-9. PubMed ID: 24191762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of airway inflammation in cystic fibrosis.
    Konstan MW
    Curr Opin Pulm Med; 1996 Nov; 2(6):452-6. PubMed ID: 9363184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of the pharmacokinetics of non-steroidal anti-inflammatory drugs (NSAIDs) in children.
    Pons G
    Clin Exp Rheumatol; 1993; 11 Suppl 9():S57-8. PubMed ID: 8354011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory approaches to the treatment of cystic fibrosis lung disease: past, present and future.
    Oermann CM
    Curr Opin Investig Drugs; 2001 Jul; 2(7):900-6. PubMed ID: 11757788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyloric channel stricture secondary to high-dose ibuprofen therapy in a patient with cystic fibrosis.
    Bell EA; Grothe R; Zivkovich V; Foote JM; Wellendorf J
    Ann Pharmacother; 1999 Jun; 33(6):693-6. PubMed ID: 10410182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ibuprofen: from invention to an OTC therapeutic mainstay.
    Rainsford KD
    Int J Clin Pract Suppl; 2013 Jan; (178):9-20. PubMed ID: 23163543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.